deltatrials
Completed PHASE3 NCT00170196

Efficacy Studies of Corticosteroid Therapy in Community-Acquired Pneumonia

The CAPISCE-Trial: Community-Acquired Pneumonia; an Intervention Study With Corticosteroids

Sponsor: Medical Center Alkmaar

Conditions Pneumonia
Interventions prednisone
Updated 5 times since 2017 Last updated: Sep 26, 2008 Started: Aug 31, 2005 Primary completion: Aug 31, 2008 Completion: Sep 30, 2008

This PHASE3 trial investigates Pneumonia and is currently completed. Medical Center Alkmaar leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical Center Alkmaar
Data source: Medical Center Alkmaar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Alkmaar, Netherlands